Podcast
Monty Pal
How a Bold Yes Became a Scientific Breakthrough
Clips
Summary
Dr. Linda Malkas shares the story behind AOH1996—how one bold “yes” led to a new cancer drug and a legacy built from love and science.
Welcome back to Season 2 On the Edge of Breakthrough: Voices of Cancer Research. In this powerful episode, Dr. Monty Pal welcomes Dr. Linda Malkas, Dean of Translational Sciences at City of Hope, for a conversation that spans childhood stargazing in Queens to leading one of the most ambitious cancer drug developments in recent history.
Dr. Malkas shares how a chance encounter with a grieving father sparked her quest to take on an “undruggable” target, resulting in AOH1996, a promising molecule designed to selectively attack cancer cells while sparing healthy ones. Named in memory of 8-year-old Ana Olivia Healy, the drug is now moving through clinical trials and showing potential to improve standard of care treatments across multiple cancers.
This episode dives into the science, the setbacks, and the synchronicity that fueled this journey, from organic chemistry and DNA fascination to late-night lab work, multidisciplinary collaboration, and the unique ecosystem at City of Hope that made it all possible.
It’s a remarkable story of science, heart, and the human drive to say “yes” to the impossible. Listen now.
Related Topics
You May Also Like
Monty Pal
Podcast
Monty Pal
Reengineering CAR T for Solid Tumors: What Glioblastoma Has Taught Us with Christine Brown, Ph.D.
Article
Haiqing Isaac Dai, Yulia Vugmeyster, Naveen Mangal
Characterizing Exposure–Response Relationship for Therapeutic Monoclonal Antibodies in Immuno-Oncology and Beyond: Challenges, Perspectives, and Prospects
Article
Doreen A. Ezeife MD, Francois Dionne PhD, Aline Fusco Fares MD, Ellen Laura Rose Cusano MD, Rouhi Fazelzad BSc, MISt, Wenzie Ng BSc, MPharm, RPh, Don Husereau BSc Pharm, MSc, Farzad Ali BPharm, MSc, Christina Sit MSc, Barry Stein B.Com BCL, LLB, Jennifer
Value assessment of oncology drugs using a weighted criterion-based approach
Article
Kelvin Chan, Seungree Nam, Bill Evans, Claire de Oliveira Alexandra Chambers, Scott Gavura, Jeffrey Hoch, Rebecca E Mercer, Wei Fang Dai, Jaclyn Beca, Mina Tadrous, Wanrudee Isaranuwatchai
Developing a framework to incorporate real-world evidence in cancer drug funding decisions: the Canadian Real-world Evidence for Value of Cancer Drugs (CanREValue) collaboration
Article
Jakub P. Hlávka, PhD, Pei-Jung Lin, PhD, Peter J. Neumann, ScD